DEF: Zynex, Inc. Announces 2025 Annual Meeting of Stockholders, Outlines Key Proposals

Zynex, Inc. has scheduled its 2025 Annual Meeting of Stockholders for May 15, 2025, to address the election of directors and ratification of the independent public accountant.

Summary

• Zynex, Inc. will hold its 2025 Annual Meeting of Stockholders on May 15, 2025, at its corporate headquarters in Englewood, Colorado.
• The primary agenda includes the election of four director nominees to serve until the 2026 Annual Meeting and the ratification of CBIZ CPAs P.C. as the independent public accountant for the fiscal year ending December 31, 2025.
• Stockholders of record as of March 18, 2025, are eligible to vote.
• The Board of Directors recommends voting for the election of all director nominees and for the ratification of CBIZ CPAs P.C.
• Proxy materials are available online, and stockholders can vote via the Internet, telephone, or mail.
• As of the record date, Zynex had 30,227,354 shares of common stock outstanding.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, outlining the details of the upcoming annual meeting and related proposals. The sentiment is neutral to slightly positive due to the standard corporate governance practices and clear communication with shareholders.

Positives

• The company is providing multiple voting options for stockholders, including online, telephone, and mail, to ensure maximum participation.
• The Board of Directors has clearly stated its recommendations on the key proposals, providing guidance to stockholders.
• The company is using the internet to distribute proxy materials, which saves costs and reduces environmental impact.
• The company has a clawback policy in place relating to recovery of erroneously awarded compensation that complies with the Nasdaq clawback rules which were required by SEC Rule 10D-1.

Negatives

• Marcum LLP resigned as the company's independent registered public accounting firm on March 26, 2025.
• The reports of Marcum regarding our financial statements for the fiscal years ended December 31, 2024 and 2023, included reportable events related to material weaknesses in the Companys internal control over financial reporting.
• Thomas Sandgaard filed one report late regarding Section 16(a) of the Exchange Act.

Risks

• Failure to ratify the selection of CBIZ as the independent registered public accounting firm could require the Audit Committee and the Board to reconsider their choice.
• The presence of forward-looking statements introduces uncertainty regarding future results, performance, and achievements.
• The company's success depends on attracting, motivating, and retaining key executives.

Future Outlook

The company provides forward-looking statements regarding its expectations, plans, and intentions, which are subject to risks and uncertainties.

Management Comments

• Thomas Sandgaard, Chairman, President, and CEO, expressed pleasure in inviting stockholders to the 2025 Annual Meeting.
• The Board believes it is important to retain flexibility in allocating the responsibilities of the CEO and Chairman of the Board in any way that is in the best interests of our Company based on the circumstances existing at a particular point in time.

Industry Context

The document provides insight into the corporate governance practices, executive compensation, and audit procedures of a medical device company, which are relevant to understanding its competitive positioning and risk management within the healthcare sector.

Comparison to Industry Standards

• The comparator group used for executive compensation benchmarking included companies like Accuray, Inc., AxoGen, Inc., and Nevro Corporation, indicating a focus on medical device and technology companies of similar size.
• The company's corporate governance practices are aligned with Nasdaq Stock Market Rules and SEC regulations.
• The company's clawback policy is in compliance with Nasdaq clawback rules which were required by SEC Rule 10D-1.

Stakeholder Impact

• Shareholders are directly impacted by the proposals being voted on, including the election of directors and the ratification of the independent public accountant.
• Employees are indirectly impacted through the executive compensation policies and the overall governance of the company.
• The company's performance and governance practices can affect its relationships with customers, suppliers, and creditors.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will report the results of the Annual Meeting in a current report on Form 8-K filed with the SEC within four business days of the meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Directors, CBIZ CPAs P.C., Stockholders, Voting, Zynex